Novavax, Inc. (NVAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.09B |
| Enterprise Value | 1.1B |
| P/E Ratio | -5.88 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 3.55 |
| Price/Book Ratio | -7.71 |
| Enterprise/Revenue | 3.8 |
| Enterprise/EBITDA | -7.77 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.6 |
| Operating Margin | -0.55 |
AD
Management Effectiveness
| Return On Assets | -0.26 |
| Return On Equity | 1.6 |
Income Statement
| Revenue | 1.12B |
| Revenue/Share | 2.51 |
| Gross Profit | 1.05B |
| EBITDA | 492.33M |
| Net Income | 440.3M |
| Diluted EPS | 2.54 |
Balance Sheet
| Total Cash | 719.34M |
| Total Cash/Share | 4.37 |
| Total Debt | 295.6M |
| Total Debt/Equity | -1.55 |
| Current Ratio | 2.33 |
| Book Value Per Share | -1.16 |
Price History
| 52-Week Change | 14.03 |
| 52-Week High | 11.97 |
| 52-Week Low | 6.2 |
| Moving Average 50 Days | 8.46 |
| Moving Average 200 Days | 8.44 |
Statistics
| Average Volume | 4.31M |
| Shares Outstanding | 164.44M |
| % Held by Institutions | 72.59 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | May 10, 2019 |
AD
